135 related articles for article (PubMed ID: 28771681)
21. [Molecular mechanism and treatment of juvenile myelomonocytic leukemia (JMML)].
Manabe A
Rinsho Ketsueki; 2012 Aug; 53(8):729-33. PubMed ID: 22975811
[No Abstract] [Full Text] [Related]
22. Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia.
Pérez B; Kosmider O; Cassinat B; Renneville A; Lachenaud J; Kaltenbach S; Bertrand Y; Baruchel A; Chomienne C; Fontenay M; Preudhomme C; Cavé H
Br J Haematol; 2010 Dec; 151(5):460-8. PubMed ID: 20955399
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic dysregulation of the erythropoietic transcription factor KLF1 and the β-like globin locus in juvenile myelomonocytic leukemia.
Fluhr S; Krombholz CF; Meier A; Epting T; Mücke O; Plass C; Niemeyer CM; Flotho C
Epigenetics; 2017 Aug; 12(8):715-723. PubMed ID: 28749240
[TBL] [Abstract][Full Text] [Related]
24. Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network.
Caye A; Strullu M; Guidez F; Cassinat B; Gazal S; Fenneteau O; Lainey E; Nouri K; Nakhaei-Rad S; Dvorsky R; Lachenaud J; Pereira S; Vivent J; Verger E; Vidaud D; Galambrun C; Picard C; Petit A; Contet A; Poirée M; Sirvent N; Méchinaud F; Adjaoud D; Paillard C; Nelken B; Reguerre Y; Bertrand Y; Häussinger D; Dalle JH; Ahmadian MR; Baruchel A; Chomienne C; Cavé H
Nat Genet; 2015 Nov; 47(11):1334-40. PubMed ID: 26457648
[TBL] [Abstract][Full Text] [Related]
25. Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing induction regimen.
Schmutz M; Zucknick M; Schlenk RF; Mertens D; Benner A; Weichenhan D; Mücke O; Döhner K; Plass C; Bullinger L; Claus R
Clin Epigenetics; 2023 Oct; 15(1):171. PubMed ID: 37885041
[TBL] [Abstract][Full Text] [Related]
26. RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia.
Poetsch AR; Lipka DB; Witte T; Claus R; Nöllke P; Zucknick M; Olk-Batz C; Fluhr S; Dworzak M; De Moerloose B; Starý J; Zecca M; Hasle H; Schmugge M; van den Heuvel-Eibrink MM; Locatelli F; Niemeyer CM; Flotho C; Plass C
Epigenetics; 2014 Sep; 9(9):1252-60. PubMed ID: 25147919
[TBL] [Abstract][Full Text] [Related]
27. [Research advances in aberrant DNA methylation in juvenile myelomonocytic leukemia].
Liang WR; Yang WY; Zhu XF
Zhonghua Er Ke Za Zhi; 2020 Sep; 58(9):776-779. PubMed ID: 32872721
[TBL] [Abstract][Full Text] [Related]
28. 5-azacytidine enhances efficacy of multiple chemotherapy drugs in AML and lung cancer with modulation of CpG methylation.
Füller M; Klein M; Schmidt E; Rohde C; Göllner S; Schulze I; Qianli J; Berdel WE; Edemir B; Müller-Tidow C; Tschanter P
Int J Oncol; 2015 Mar; 46(3):1192-204. PubMed ID: 25501798
[TBL] [Abstract][Full Text] [Related]
29. Juvenile myelomonocytic leukaemia: a case series.
Azma RZ; Zarina AL; Hamidah A; Jamal R; Sharifah NA; Ainoon O; Hamidah NH
Malays J Pathol; 2009 Dec; 31(2):121-8. PubMed ID: 20514855
[TBL] [Abstract][Full Text] [Related]
30. Recent advances in the pathogenesis and management of juvenile myelomonocytic leukaemia.
Koike K; Matsuda K
Br J Haematol; 2008 May; 141(5):567-75. PubMed ID: 18422786
[TBL] [Abstract][Full Text] [Related]
31. Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents.
Merlevede J; Droin N; Qin T; Meldi K; Yoshida K; Morabito M; Chautard E; Auboeuf D; Fenaux P; Braun T; Itzykson R; de Botton S; Quesnel B; Commes T; Jourdan E; Vainchenker W; Bernard O; Pata-Merci N; Solier S; Gayevskiy V; Dinger ME; Cowley MJ; Selimoglu-Buet D; Meyer V; Artiguenave F; Deleuze JF; Preudhomme C; Stratton MR; Alexandrov LB; Padron E; Ogawa S; Koscielny S; Figueroa M; Solary E
Nat Commun; 2016 Feb; 7():10767. PubMed ID: 26908133
[TBL] [Abstract][Full Text] [Related]
32. [Molecular mechanism and progress in treatment of juvenile myelomonocytic leukemia (JMML)].
Koike K; Matsuda K
Rinsho Ketsueki; 2013 Jun; 54(6):538-44. PubMed ID: 23823092
[No Abstract] [Full Text] [Related]
33. Aberrant DNA Methylation Is Associated with a Poor Outcome in Juvenile Myelomonocytic Leukemia.
Sakaguchi H; Muramatsu H; Okuno Y; Makishima H; Xu Y; Furukawa-Hibi Y; Wang X; Narita A; Yoshida K; Shiraishi Y; Doisaki S; Yoshida N; Hama A; Takahashi Y; Yamada K; Miyano S; Ogawa S; Maciejewski JP; Kojima S
PLoS One; 2015; 10(12):e0145394. PubMed ID: 26720758
[TBL] [Abstract][Full Text] [Related]
34. Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options.
Niemeyer CM; Kratz CP
Br J Haematol; 2008 Mar; 140(6):610-24. PubMed ID: 18302710
[TBL] [Abstract][Full Text] [Related]
35. Management of Two Juvenile Myelomonocytic Leukemia Patients According to Clinical and Genetic Features.
Tüfekçi Ö; Ören H; Demir Yenigürbüz F; Gözmen S; Karapınar TH; İrken G
Turk J Haematol; 2015 Jun; 32(2):175-9. PubMed ID: 26316488
[TBL] [Abstract][Full Text] [Related]
36. Concurrent juvenile myelomonocytic leukemia and T-lymphoblastic lymphoma with a shared missense mutation in NRAS.
Ly B; Modi A; Rogers HJ; Makishima H; Hanna R; Cook JR; Theil KS; Maciejewski JP
Pediatr Blood Cancer; 2014 May; 61(5):946-8. PubMed ID: 24610751
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and treatment of juvenile myelomonocytic leukemia in Slovak Republic: novel approaches.
Fabri O; Horakova J; Bodova I; Svec P; Laluhova Striezencova Z; Bubanska E; Cermak M; Galisova V; Skalicka K; Vaska A; Doczyova D; Panikova A; Sykora T; Adamcakova J; Kolenova A
Neoplasma; 2019 Sep; 66(5):818-824. PubMed ID: 31129971
[TBL] [Abstract][Full Text] [Related]
38. A MBD-seq protocol for large-scale methylome-wide studies with (very) low amounts of DNA.
Aberg KA; Chan RF; Shabalin AA; Zhao M; Turecki G; Staunstrup NH; Starnawska A; Mors O; Xie LY; van den Oord EJ
Epigenetics; 2017 Sep; 12(9):743-750. PubMed ID: 28703682
[TBL] [Abstract][Full Text] [Related]
39. Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia.
Loh ML
Br J Haematol; 2011 Mar; 152(6):677-87. PubMed ID: 21623760
[TBL] [Abstract][Full Text] [Related]
40. [Advances in the treatment of juvenile myelomonocytic leukemia].
Cai YL; Zhang JL; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2018 Nov; 20(11):958-963. PubMed ID: 30477631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
